Neoadjuvant Study of HIFU With or Without PD-1 Inhibitors Followed by Abraxane Plus Carboplatin in Triple-Negative Breast Cancer.
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Abraxane
Related studies linked through entity extraction aliases.
Phase II Trial of Albumin-Bound Paclitaxel Combined With Nedaplatin (TP) Via Hepatic Arterial Infusion for Advanced Breast Cancer Patients With Liver Metastases After Failure of Standard Therapy
- Status
- RECRUITING
- Phase
- PHASE2
Prospective Trial Assessing Real World Outcomes Response to Pembro in Black Patients w/ NSCLC
- Status
- RECRUITING
- Phase
- PHASE2
Abequolixron (RGX-104) and Durvalumab in Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Envafolimab Combined With Abraxane and Cisplatinas as Neoadjuvant Treatment for Resectable Esophageal Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
CAR-DC Vaccine and ICIs in Local Advanced/Metastatic Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Combination of CAR-DC Vaccine and ICIs in Malignant Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or ICI, for the Treatment of Patients With Advanced Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
9-ING-41 Plus Retifanlimab and Gemcitabine/Nab-Paclitaxel in Patients With Advanced Pancreatic Adenocarcinoma
- Status
- TERMINATED
- Phase
- PHASE2
Pyrotinib, Trastuzumab And Abraxane in HER2-positive MBC With Brain Metastasis
- Status
- UNKNOWN
- Phase
- PHASE2
Apatinib Combined With Abraxane and Carboplatin or Cisplatinum as First-line Treatment for Epithelial Ovarian Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
MRI Effects of Pegvorhyaluronidase Alfa (PEGPH20) in Pancreatic Ductal Adenocarcinoma
- Status
- WITHDRAWN
- Phase
- PHASE2
ORIN1001 in Patients with Advanced Solid Tumors and Relapsed Refractory Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Abraxane Combined With Xeloda as Neo-Adjuvant Chemotherapy in Early Breast Cancer
- Status
- UNKNOWN
- Phase
- NA
The Efficacy and Safety of Abraxane Combined With Epirubicin as Neoadjuvant Chemotherapy in Breast Cancer
- Status
- UNKNOWN
- Phase
- NA
Combination Nab-paclitaxel (N-P) and Nintedanib or N-P and Placebo in Relapsed NSCLC Adenocarcinoma
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Abraxane With Anti-PD1/PDL1 in Patients With Advanced Urothelial Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Afatinib and Gemcitabine/Nab-paclitaxel in Metastatic Pancreatic Cancer
- Status
- UNKNOWN
- Phase
- PHASE1
A Phase 2 Feasibility Study of Abraxane and Carboplatin in Epithelial Neoplasms of the Uterus
- Status
- COMPLETED
- Phase
- PHASE2
Abraxane in Patients With Visceral Metastases Dominant Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2